Nicotinamide mononucleotide (NMN) has become one of the most searched-for ingredients in the longevity and healthy-aging supplement space, and for good reason.
As a direct precursor to nicotinamide adenine dinucleotide (NAD+), a molecule that cells rely on for energy production and repair, NMN supplementation has drawn significant interest from consumers looking to support healthy aging.
But not all NMN supplements are created equal, and independent testing has raised concerns about potency and label accuracy across the category. Rokit NMN, from Rokit America, offers a real-world example of how one company has approached safety and quality: it has completed both GLP-based safety testing and Self-Affirmed Generally Recognized as Safe (GRAS) review.
What is NMN, and why does sourcing matter?
NMN is a naturally occurring compound the body uses to produce NAD+, a coenzyme involved in energy metabolism, DNA repair, and cellular health – all processes that decline with age. That has driven strong consumer demand for NMN supplements as a NAD+ booster.
But demand has outpaced quality control. NMN manufacturing and purification require specialized processes, purity, solvent safety, and particle consistency vary considerably from one supplier to the next, and those differences aren’t visible on a typical supplement label.
What independent testing has found
The concern is documented. In a study published in GeroScience in 2024, Sandalova and colleagues at the National University of Singapore’s Yong Loo Lin School of Medicine analyzed 18 commercially available NMN supplements using high-performance liquid chromatography coupled with mass spectrometry.1 Measured NMN content ranged from 100% below to 11.2% above the amount stated on the label.
Three of the 18 products contained no detectable NMN at all, and most of the others fell short of their label claims. The authors suggested that lower readings may reflect degradation or smaller amounts being added, while higher readings may reflect intentional overage.
Findings like these shift the question for consumers and formulators from whether a product is popular to what evidence supports its quality and safety. In that context, it is worth looking at what a documented safety record in this category can look like.
A two-step safety validation process
Rokit NMN is manufactured to a defined, proprietary specification built around standards for potency, purity, and particle size, and its safety was not demonstrated just once. It was validated through two separate processes.
Step one was formal toxicology testing conducted at a Good Laboratory Practice (GLP)-certified institution in Korea, before any outside panel reviewed the ingredient. GLP certification is an internationally recognized standard for the conduct of non-clinical safety studies, and this testing established the initial, documented basis for the ingredient’s safety profile. According to the company, Rokit NMN is a well-established NMN product in the Korean market and is recognized there as one of the leading NMN brands.
Step two was Self-Affirmed GRAS review. A panel of credentialed experts in the US with established careers in toxicology reviewed the complete safety dossier, including purity data, batch consistency, genotoxicity testing, and a formally calculated safety margin, and concluded the ingredient is safe as intended.
Together, the two steps mean safety was demonstrated once through certified toxicology testing, then reaffirmed through an independent expert review. The company notes that this layered approach is not commonly disclosed in the NMN category.
Purity and solvent safety: What “high-purity NMN” actually means
“High purity” is a common claim in NMN marketing, but it’s rarely backed by specifics. ROKIT NMN’s purification process was designed to remove impurities at every manufacturing stage, resulting in what the company describes as one of the more highly refined NMN products available.
Just as important, no solvents classified as hazardous under California’s Proposition 65 were used at any point in the purification process; only solvents independently verified as safe were used throughout manufacturing. Rigorous impurity removal paired with verified solvent safety is a detail many NMN brands do not publicly disclose.
What the self-affirmed GRAS panel found
Readers weighing whether a given NMN supplement is safe may want to know what this kind of independent review actually covers.
This is what the panel examined:
Purity and manufacturing consistency: The ingredient is manufactured to a validated purity standard of 99% or higher, confirmed by High-Performance Liquid Chromatography (HPLC) diode-array testing across three separate, non-consecutive production batches. Manufacturing follows current Good Manufacturing Practice (cGMP) requirements under Title 21 of the Code of Federal Regulations (CFR), Part 117, and shelf-life studies support a 24-month stability window.
Safety margin: A 90-day toxicology study found no adverse effects at doses up to 800 mg per kilogram of body weight per day, the highest dose tested. Compared against typical US dietary NMN intake, the panel calculated a safety margin of roughly 269 times what a typical consumer would realistically consume.
Genotoxicity and human clinical data: A battery of genotoxicity assays, including bacterial reverse mutation tests, a mammalian chromosomal aberration test, and an in vivo micronucleus assay, found no evidence of genotoxic potential. Published human clinical trials at doses up to 1,250 mg per day over four weeks and 250 mg per day over twelve weeks reported no safety concerns.
Self-affirmed GRAS vs. FDA approval: What’s the difference?
A common point of confusion in NMN research is what GRAS actually means. It is a regulatory classification under US food law, and there are two paths to it: direct review by the FDA, or a self-affirmation process in which independent experts evaluate the safety data themselves.
This ingredient followed the self-affirmation path, with the review convened by AIBMR Life Sciences, Inc., a Seattle-based scientific and regulatory consulting firm, and conducted by credentialed US toxicology experts.
Self-affirmed GRAS status is not the same as FDA approval; the FDA did not review this specific product. But it does reflect the independent judgment of qualified experts, with no obligation to reach any particular conclusion, examining the full body of safety evidence and putting their professional credentials behind it.
Frequently asked questions
Q: What is the difference between NMN and NAD+?
A: NMN is a precursor molecule the body converts into NAD+. Supplementing with NMN is one approach researchers and consumers use to support the body’s NAD+ levels, since NAD+ itself is difficult for the body to absorb directly.
Q: Do NMN supplements always contain what the label says?
A: Not necessarily. A 2024 analysis of 18 commercially available NMN supplements published in GeroScience found measured NMN content ranging from 100% below to 11.2% above label claims, including three products with no detectable NMN.
Q: How can a consumer tell if an NMN supplement is high quality?
A: Look for third-party purity verification such as HPLC testing, a stated purity percentage (99%+ is considered high-purity), transparency around manufacturing standards such as cGMP certification, and independent safety review such as Self-Affirmed GRAS.
Q: Is self-affirmed GRAS status the same as FDA approval?
A: No. Self-Affirmed GRAS means independent experts, rather than the FDA, reviewed the safety data and reached a conclusion. It is a legitimate, established form of third-party review, but a distinct regulatory pathway from FDA approval.
Q: What safety validation has Rokit NMN completed?
A: Rokit NMN has completed two separate safety validation steps: toxicology testing at a GLP-certified institution in Korea and a self-affirmed GRAS panel review, alongside a purification process the company says is free of Proposition 65-hazardous solvents.
The bottom line
Quality and purity vary significantly across the NMN supplement market, and independent testing shows that much of that variation is invisible to consumers reading a label. Rokit NMN is one example of how a company can address that gap: GLP-based safety testing followed by self-affirmed GRAS review, supported by a high-purity specification and verified solvent safety.
As scrutiny of the category grows, documented, third-party evidence of this kind offers a clearer basis for judging NMN quality than labeling alone.
References
- Sandalova, E.; et al. Testing the amount of nicotinamide mononucleotide and urolithin A as compared to the label claim. GeroScience. 2024;46(5):5075–5083.